Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Cancer Immunol Immunother. 2015 Sep 21;64(12):1531–1539. doi: 10.1007/s00262-015-1758-5
1) Outcome: IR Predictors: stage, age, gender, cohort group (high- versus low-responder arms)
2a) Outcomes: OS, DFS Predictors: stage, age, gender, immune response (all participants)
2b) Outcomes: OS, DFS Predictors: stage, age, gender, immune response (only participants from high responder arms (Mel43 A & C) and (Mel44 A & B)